BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36271504)

  • 21. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice.
    Suriben R; Chen M; Higbee J; Oeffinger J; Ventura R; Li B; Mondal K; Gao Z; Ayupova D; Taskar P; Li D; Starck SR; Chen HH; McEntee M; Katewa SD; Phung V; Wang M; Kekatpure A; Lakshminarasimhan D; White A; Olland A; Haldankar R; Solloway MJ; Hsu JY; Wang Y; Tang J; Lindhout DA; Allan BB
    Nat Med; 2020 Aug; 26(8):1264-1270. PubMed ID: 32661391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GFRAL-expressing neurons suppress food intake via aversive pathways.
    Sabatini PV; Frikke-Schmidt H; Arthurs J; Gordian D; Patel A; Rupp AC; Adams JM; Wang J; Beck Jørgensen S; Olson DP; Palmiter RD; Myers MG; Seeley RJ
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice.
    Fichtner K; Kalwa H; Lin MM; Gong Y; Müglitz A; Kluge M; Krügel U
    Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GDNF family receptor alpha-like antagonist antibody alleviates chemotherapy-induced cachexia in melanoma-bearing mice.
    Lee BY; Jeong J; Jung I; Cho H; Jung D; Shin J; Park JK; Park E; Noh S; Shin S; Kang S; Heo JI; Baek MC; Yea K
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1441-1453. PubMed ID: 37017344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.
    Guo X; Asthana P; Zhai L; Cheng KW; Gurung S; Huang J; Wu J; Zhang Y; Mahato AK; Saarma M; Ustav M; Kwan HY; Lyu A; Chan KM; Xu P; Bian ZX; Wong HLX
    Nat Commun; 2024 Feb; 15(1):1034. PubMed ID: 38310105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress.
    Ost M; Igual Gil C; Coleman V; Keipert S; Efstathiou S; Vidic V; Weyers M; Klaus S
    EMBO Rep; 2020 Mar; 21(3):e48804. PubMed ID: 32026535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GDF15 mediates the effects of metformin on body weight and energy balance.
    Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
    Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth differentiation factor-15 stimulates the synthesis of corticotropin-releasing factor in hypothalamic 4B cells.
    Tasso M; Kageyama K; Iwasaki Y; Watanuki Y; Niioka K; Takayasu S; Daimon M
    Peptides; 2023 Dec; 170():171112. PubMed ID: 37918484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of growth differentiation factor 15 (GDF15) in metabolic diseases.
    Li J; Hu X; Xie Z; Li J; Huang C; Huang Y
    Biomed Pharmacother; 2024 Jul; 176():116809. PubMed ID: 38810400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling.
    Worth AA; Shoop R; Tye K; Feetham CH; D'Agostino G; Dodd GT; Reimann F; Gribble FM; Beebe EC; Dunbar JD; Alexander-Chacko JT; Sindelar DK; Coskun T; Emmerson PJ; Luckman SM
    Elife; 2020 Jul; 9():. PubMed ID: 32723474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice.
    Patel AR; Frikke-Schmidt H; Bezy O; Sabatini PV; Rittig N; Jessen N; Myers MG; Seeley RJ
    Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G247-G255. PubMed ID: 34935522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise.
    Klein AB; Nicolaisen TS; Ørtenblad N; Gejl KD; Jensen R; Fritzen AM; Larsen EL; Karstoft K; Poulsen HE; Morville T; Sahl RE; Helge JW; Lund J; Falk S; Lyngbæk M; Ellingsgaard H; Pedersen BK; Lu W; Finan B; Jørgensen SB; Seeley RJ; Kleinert M; Kiens B; Richter EA; Clemmensen C
    Nat Commun; 2021 Feb; 12(1):1041. PubMed ID: 33589633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Growth Differentiation Factor 15 in Energy Metabolism.
    Chang JY; Hong HJ; Kang SG; Kim JT; Zhang BY; Shong M
    Diabetes Metab J; 2020 Jun; 44(3):363-371. PubMed ID: 32613776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GDF15 promotes weight loss by enhancing energy expenditure in muscle.
    Wang D; Townsend LK; DesOrmeaux GJ; Frangos SM; Batchuluun B; Dumont L; Kuhre RE; Ahmadi E; Hu S; Rebalka IA; Gautam J; Jabile MJT; Pileggi CA; Rehal S; Desjardins EM; Tsakiridis EE; Lally JSV; Juracic ES; Tupling AR; Gerstein HC; Paré G; Tsakiridis T; Harper ME; Hawke TJ; Speakman JR; Blondin DP; Holloway GP; Jørgensen SB; Steinberg GR
    Nature; 2023 Jul; 619(7968):143-150. PubMed ID: 37380764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nuclei RNA sequencing of the rat AP and NTS following GDF15 treatment.
    Reiner BC; Crist RC; Borner T; Doyle RP; Hayes MR; De Jonghe BC
    Mol Metab; 2022 Feb; 56():101422. PubMed ID: 34942400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?
    Klein AB; Kleinert M; Richter EA; Clemmensen C
    Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34849709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15.
    Cimino I; Kim H; Tung YCL; Pedersen K; Rimmington D; Tadross JA; Kohnke SN; Neves-Costa A; Barros A; Joaquim S; Bennett D; Melvin A; Lockhart SM; Rostron AJ; Scott J; Liu H; Burling K; Barker P; Clatworthy MR; Lee EC; Simpson AJ; Yeo GSH; Moita LF; Bence KK; Jørgensen SB; Coll AP; Breen DM; O'Rahilly S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34187898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL.
    Zhao Z; Zhang J; Yin L; Yang J; Zheng Y; Zhang M; Ni B; Wang H
    Aging (Albany NY); 2020 Nov; 12(22):22564-22581. PubMed ID: 33201838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of GDF15 as a Myomitokine.
    Johann K; Kleinert M; Klaus S
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creation of a Peptide Antagonist of the GFRAL-RET Receptor Complex for the Treatment of GDF15-Induced Malaise.
    Borner T; Tinsley IC; Milliken BT; Doebley SA; Najjar NR; Kerwood DJ; De Jonghe BC; Hayes MR; Doyle RP
    J Med Chem; 2023 Aug; 66(16):11237-11249. PubMed ID: 37506293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.